Immunologic and Targeted Molecular Therapies for Chordomas: A Narrative Review
Journal of Clinical Medicine · 24.09.2024 · 13 (19) · 5679
DOI: 10.3390/jcm13195679 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 24.09.2024. Verfasst von Regina Golding und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Montefiore Einstein, Bronx, NY 10461, USA. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Chordomas are rare sarcomas arising from notochordal tissue and occur most commonly in the spine. The standard of care for chordomas without evidence of metastatic disease generally consists of en bloc resection followed by adjuvant radiotherapy. However, long-term (20-year) survival rates are approximately 30%. Chordomas are generally considered as chemo resistant. Therefore, systemic therapies have rarely been employed. Novel immunotherapies, including antibody therapy and tumor vaccines, have shown promise in early trials, leading to extended progression-free survival and symptom relief. However, the outcomes of larger trials using these vectors are heterogeneous. The aim of this review is to summarize novel chordoma treatments in immune-targeted therapies. The current merits, trial outcomes, and toxicities of these novel immune and targeted therapies, including those targeting vascular endothelial growth factor receptor (VEGFR) targets and the epidermal growth factor receptor (EGFR), will be discussed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Montefiore Einstein, Bronx, NY 10461, USA.
- Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
- Department of Neurological Surgery, Montefiore Einstein, Bronx, NY 10461, USA.
ORCID-Profile: Rami Abuqubo, Rafael De la Garza Ramos, Mitchell S Fourman
Zitieren
APA
Golding, R., Abuqubo, R., Pansa, C. J., Bhatta, M., Shankar, V., Mani, K., Kleinbart, E., Gelfand, Y., Murthy, S., De la Garza Ramos, R., Krystal, J., Eleswarapu, A., Yassari, R., Mostafa, E., Fourman, M. S., & Schlumprecht, A. (2024). Immunologic and Targeted Molecular Therapies for Chordomas: A Narrative Review. Journal of Clinical Medicine, 13(19), 5679. https://doi.org/10.3390/jcm13195679
Vancouver
Golding R, Abuqubo R, Pansa CJ, Bhatta M, Shankar V, Mani K, et al. Immunologic and Targeted Molecular Therapies for Chordomas: A Narrative Review. Journal of Clinical Medicine. 2024;13(19):5679. doi:10.3390/jcm13195679
BibTeX
@article{Golding2024,
author = {Golding, Regina and Abuqubo, Rami and Pansa, Christopher J and Bhatta, Manish and Shankar, Vishal and Mani, Kyle and Kleinbart, Emily and Gelfand, Yaroslav and Murthy, Saikiran and De la Garza Ramos, Rafael and Krystal, Jonathan and Eleswarapu, Ananth and Yassari, Reza and Mostafa, Evan and Fourman, Mitchell S and Schlumprecht, Anne},
title = {Immunologic and Targeted Molecular Therapies for Chordomas: A Narrative Review},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {19},
pages = {5679},
doi = {10.3390/jcm13195679}
}
EUVIMED